This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.

Objectives: This study aimed to evaluate the effectiveness of value-based care (VBC) interventions in slowing the progression of chronic kidney disease (CKD), as measured by changes in estimated ...

While Ashley McEvoy has only been at the helm of Insulet for five months, she's already seeing the increasing role of AI in ...

Background Despite global efforts to improve nutrition, young women aged 15–24 years in low-income and middle-income countries (LMICs) face persistent dual burdens of malnutrition, marked by high ...

A major study from Tübingen found that prediabetic individuals who normalized their blood sugar through healthy habits — even ...

Biomea Fusion's experimental drug showed sustained blood sugar control in patients with type 2 diabetes and may benefit those not responding to GLP-1 therapies like Novo Nordisk's Ozempic, it said on ...

Scientists at City of Hope have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 ...

Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a ...

AI-driven care models have led to significant reductions in both healthcare expenses and HbA1c levels for diabetic patients ...

This episode of Pharma Pulse covers new research showing how obesity at age 20 increases postpartum diabetes risk, Amgen’s ...